2018. A Randomized study of sofosbuvir plus ribavirin with and without PEG interferon alpha 2b in treatment of hepatitis C genotype 3 infection: Real life data from a Tertiary Care Center. International Journal of Biomedical and Advance Research. 9, 3 (Apr. 2018), 91–95. DOI:https://doi.org/10.7439/ijbar.v9i3.4673.